miR-33a directly targeted cyclin-dependent kinases 6 (CDK6), cell cycle protein D1 (CCND1), and serine/threonine kinase PIM-1, and expression was down-regulated in gastric cancer tissues and cell lines, thereby inhibiting gastric cancer cell proliferation [143]. Here, CDK6 is linked to gastric cancer.